March 28, 2006

The FDA has quietly adopted a radical policy to boost the biotech-pharmaceutical industry. The drug, TGN1412, a

Read More
Disasterous Drug Trial_FDA New Rules Ensure More Disasters to Follow

March 3, 2006

Biogen and Elan, the manufacturers of the drug, Tysabri, refused to release her medical records and imaging

Read More
FDA Approval process under fire–PML: Lethal side-effect–Tysabri: Multiple Sclerosis Drug